Back
Veradigm 10K Form
Sell
31
MDRX
Veradigm
Last Price:
$9.50
Seasonality Move:
10.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2022-11-07 | 10Q | MDRX/Veradigm Quarterly |
| 2022-08-08 | 10Q | MDRX/Veradigm Quarterly |
| 2022-05-09 | 10Q | MDRX/Veradigm Quarterly |
| 2021-11-05 | 10Q | MDRX/Veradigm Quarterly |
| 2021-08-06 | 10Q | MDRX/Veradigm Quarterly |
| 2021-04-30 | 10Q | MDRX/Veradigm Quarterly |
Receive MDRX News And Ratings
See the #1 stock for the next 7 days that we like better than MDRX
MDRX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 14.94 |
| Annual Sales: | $0.00 |
| Price / Book: | 0.88 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $619.6M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Veradigm Earnings Forecast
Key Veradigm Financial Ratios
-
The Gross Profit Margin over the past 23 years for MDRX is 41.22%.
-
The Selling, General & Administrative Expenses for MDRX have been equal to 20.88% of Gross Profit Margin.
-
The Research & Development expenses have been 12.89% of Revenue.
-
The Interest Expense is 9.79% of Operating Income.
-
The Net Earning history of MDRX is 8.94% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 11 years.
Veradigm Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | MDRX |
| CUSIP: | 01988P |
| Website: | veradigm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.79 |
|---|---|
| Forward P/E Ratio: | 0 |